Question 1

Has Wendy Sacks, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $59,832 in general payments to Wendy Sacks, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Wendy Sacks, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Wendy Sacks, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Bayer	10	$37,740
Takeda Pharmaceuticals U.S.A., Inc.	19	$16,574
AstraZeneca	1	$3,913
Shire North American Group Inc	2	$1,605

Drug	Claims	Cost to plans & patients
SynthroidLevothyroxine Sodium	182	$14,486
MounjaroTirzepatide	14	$13,170
Levothyroxine Sodium	167	$2,019
Methimazole	23	$124
Metformin Hcl	13	$34
Alendronate Sodium	11	$31

Wendy Sacks, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other endocrinology, diabetes & metabolism in Los Angeles